ArticleBioengineering (Basel, Switzerland)2026
A Subject-Specific Cerebrovascular CFD Modeling Approach Based on a Multimodal Data-Driven Boundary Calibration Framework: A Proof-of-Concept Study.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cerebrovascular computational fluid dynamics (CFD) models often rely on generic boundary conditions, which may limit their ability to represent subject-specific hemodynamics and cerebral autoregulation (CA). We propose a multimodal data-driven boundary calibration (MDBC) framework integrating transcranial color-coded Doppler and continuous blood pressure monitoring to optimize individualized outlet resistances. As a proof-of-concept, we evaluated the MDBC framework in a single healthy volunteer at resting baseline and enhanced external counterpulsation (EECP)-a hemodynamic perturbation potentially triggering CA. Compared with conventional open boundary (OB) and static Murray allocation boundary (SMAB) strategies, MDBC achieved closer agreement with in vivo middle cerebral artery (MCA) velocity waveforms under both states. At rest, MDBC's left MCA relative root mean square error (rRMSE) was 7.19%, versus 22.85% (OB) and 30.89% (SMAB). During EECP, conventional models yielded rRMSEs > 32%, whereas MDBC maintained 11.24%. Meanwhile, MDBC reproduced inter-hemispheric perfusion imbalance, an EECP-induced flow surge in the right MCA, and pronounced wall shear stress increases that were masked by generic boundary strategies. Moreover, MDBC estimated a 25.8% increase in global cerebrovascular resistance during EECP, suggesting the capability of the framework to characterize subject-specific impedance adaptations potentially associated with CA during intervention. These single-subject findings support the technical feasibility of integrating multimodal physiological measurements into cerebrovascular CFD boundary calibration and warrant further validation in larger cohorts and patient populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.